Profit

Prabhudas Lilladher's top picks

PUBLISHED ON: May 10, 2010 | Duration: 2 min, 58 sec

  
loading..
Dilip Bhat, Jt MD of Prabhudas Lilladher, says from the pharma pack, Ranbaxy really looks good and in the multinational space GlaxoSmithKline and Pfizer looks very solid. In the midcap space, Divis Labs can give phenomenal returns in 2-3 years period.
ALSO WATCH
पॉलिटिक्स का चैंपियन कौन: मोदी सरकार का अर्थशास्त्र पास या फेल?

................................ Advertisement ................................

................................ Advertisement ................................